Search

everythinglearnresearchcommunity

for

Search:↓

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Some supplements and hormones can increase hair loss by raising DHT levels.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

PSA can help diagnose high androgen levels in women.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Spironolactone with an oral contraceptive improved hair growth in women with hirsutism.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Birth control pills help treat acne, especially when caused by excess male hormones, and are safe to use with antibiotics.

People with androgenetic alopecia, both men and women, are more likely to develop heart diseases in the future.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.